Signal2026-05-22
openFDA Drug Data

[FDA Approval] PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF)

Part of

Phase 2 Clinical Trial Developments

Open primary sourceSee the whole picture